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Abstract  
Background: Several cross-sectional studies have reported lower aerobic fitness among 
fibromyalgia (FM) patients compared to healthy controls. At present it is unknown whether 
the inferior aerobic fitness is a cause or a consequence of the illness. 
Objective: To examine if female FM patients have the same ability to enhance their aerobic 
fitness as healthy sedentary controls matched on age and BMI. A second objective was to 
investigate whether the FM patients experience an increase in pressure pain threshold (PPT) 
following an aerobic exercise program.  
Methods: Fifty subjects (25 FM patients, 25 controls) were enrolled to a 12 week aerobic 
exercise program. The exercise program consisted of ergometer cycling two times a week 
(each session 45-55 min) at low to moderate intensity. An incremental ergometer test was 
performed to determine anaerobic threshold (AT), and exercise intensity was deduced from 
the AT data acquired. Main outcome was changes in spirometric values and watt production 
at AT. Second outcome was changes in PPTs measured by an algometer. 
Results: FM patients were equally exercisable as healthy matched sedentary controls. No 
significant differences were found in average changes in VO2 (P=0.53) and watt production 
(P=0.56) at AT following the exercise program. However, FM patients had lower VO2 and 
watt production compared to controls at both the pre- and post test (P<0.03 for all 
comparisons). No significant increase in PPT was observed within the FM group following 
the exercise program (P>0.1 for all recorded PPT sits).   
Discussion: Aerobic exercise with low to moderate intensity enhances aerobic fitness in FM 
patients to the same extent as in healthy sedentary controls. A substantial lower aerobic fitness 
was found in the FM patients at both pre- and post test. These findings indicate that the 
common observation of low aerobic fitness among FM patients is related to inactivity rather 
than the illness.  
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Introduction 
Fibromyalgia syndrome (FM) is a musculoskeletal illness, with a prevalence of 2-5 % 
in the general population, afflicting about seven times more women than men (Wolfe et al., 
1995; Kurtze & Svebak, 2001; Lawrence et al., 2008). FM is defined by the American 
College of Rheumatology (ACR) as an illness that includes a history of chronic widespread 
pain, and reduced pressure pain threshold (PPT) at 11 of 18 anatomically defined tender point 
sites (Wolfe et al., 1990). The definition of the illness emphasizes reduced PPT as the main 
contributing factor; however, FM patients often experience a wide range of other symptoms. 
Psychological symptoms like depression, anxiety, worries, sleep disturbances, and 
dissatisfactions with own health have all been reported among FM patients (Wolfe et al., 
1997; Epstein et al., 1999). Fatigue, irritable bowel syndrome and migraines among others, 
are more somatic symptoms, that are often present in FM patients (Clauw, 1995). However, 
the comorbidity varies widely in the FM group, with some patients reporting a wide range of 
additional symptoms, and others reporting few additional symptoms (Wilson, 2009). The 
amount or combination of additional symptoms reflects the heterogeneity of the FM 
syndrome. In addition, the FM patients are often categorized by allodynia, which means that 
normally none-painful stimuli appear painful (Price & Staud, 2005).  
The reason for developing FM is so far unknown. However, there has been some 
evidence connecting trauma and psychosocial work factors to the onset of FM. A review by 
White and co-workers (2000) investigated the relation between trauma and FM and found 
some evidence in support of a connection between the two. Harkness and co-workers (2004) 
found that psychosocial work factors were the strongest predictor for development of chronic 
musculoskeletal pain, which again is the first step against developing FM. Furthermore, 
Arnold and co-workers (2004) showed that first-degree relatives of FM patients had much 
higher tender point count compared to first-degree relatives of rheumatoid arthritis patients. 
This suggests that a genetic predisposition may be a contributing cause to developing FM. 
Pathophysiology behind FM still remains indistinct, and whether the disease has a 
central or peripheral origin has been debated the last decades. In recent years there have 
nonetheless been a tendency supporting a central mechanism as the main contributor to the 
persistent pain observed in FM patients (Abeles et al., 2007). One part of the evidence 
supporting a central mechanism is the biochemical abnormalities reported. Reduced 
concentration of dopaminergic neurotransmitters (Wood et al., 2007), reduced values of 
adrenalin during submaximal isometric exertion (Giske et al., 2008), and high concentrations 
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of substance P (Russell, 1995; Pillemer et al., 1997), have all been reported in patients with 
FM. This aberration in biochemical properties might cause reduced capacity for pain 
inhibitory signaling among FM patients (Edwards, 2005). Furthermore, a recent study by 
Goffaux and co-workers (2009) found evidence for permanent changes in excitability in the 
spinal neurons of FM patients. All these findings indicate that FM is an illness related to pain 
enhancement by central mechanisms. Nevertheless, there are some peripheral mechanisms 
associated with FM patients. Muscle abnormalities like ragged red muscle fibers, and the 
reduced amount of type 2 fibers, are both common in FM patients (Pongratz & Späth, 1998; 
Bengtsson, 2002). However, these latter findings may relate to inactivity rather than being a 
cause to the illness.   
Another important aspect of patients with FM is their level of physical fitness. There 
are  recent evidence suggesting that female FM patients have lower aerobic fitness than 
healthy controls (Valim et al., 2002; Valkeinen et al., 2008) and that female FM patients, and 
older healthy women may have similar lower-body strength (Panton et al., 2006). In addition 
to the decreased physical fitness, many FM patients have reduced ability to carry out high 
intensity exercise, and are frequently afflicted with post exercise pain and stiffness 
(Mengshoel et al., 1992; van Santen et al., 2002b). Post exercise pain might result in a more 
sedentary behavior among FM patients, which in turn reduces the physical fitness, and 
increases the likelihood of developing additional comorbiditis. However, it is currently 
unknown if low physical fitness is a contributing factor to the development of FM, e.g. due to 
a dysfunctional metabolic system in the muscles, or if it is a consequence of inactivity. 
During recent years, a large number of studies have been conducted to investigate the 
effect of aerobic exercise on FM symptoms (Mengshoel et al., 1992; Meiworm et al., 2000; 
Meyer and Lemley, 2000; Sabbag et al., 2007). The main outcome from these studies seems 
to be that FM patients can safely participate in aerobic exercise with low to moderate 
intensity, as long as the intensity is individually tailored to best reduce pain and enhance 
physical function (Busch et al., 2008). Determination of intensity varies widely in the 
previous conducted exercise interventions among FM patients. Meyer and Lemley (2000) 
used a formula based on age predicted maximum heart rate. Mengshoel and co-workers 
(1992) used exercise intensity between 120-150 beats per minute, while Richards and Scott 
(2002) used self-chosen intensity. The heterogeneity of FM patients as a group makes it 
important to individualize exercise program to the fitness level of each patient (Mannerkorpi 
& Iversen, 2003). In addition, Valim and co-workers (2002) pointed out that the best way to 
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determine individual exercise intensity in FM patients prior to entering an exercise 
intervention was to use the AT as basis for the exercise intensity. AT was achievable for 
almost all FM patients on the contrary to VO2max, which was proven difficult to attain for 
most of the FM patients. 
Studies investigating the effect of aerobic exercise on PPT or number of tender points 
in FM patients have shown inconsistent results. Gowans and co-workers (2001) found no 
significant improvement in the number of tender points following a 23 week aerobic exercise 
program. Richards and Scott (2002) on the other hand, found significant improvements in 
number of tender points following a 12 week aerobic exercise program. The intensity in the 
Richards and Scott study were self-chosen, while Gowans and co-workers used an intensity of 
60-75% of maximum heart rate retrieved from age predicted maximum heart rate (220-age) as 
their exercise intensity zone. A meta-analysis by Busch and co-workers (2008) confirm that 
changes in number of tender points following different types of aerobic exercise interventions 
among FM patients are highly inconsistent, and on an average not significant. However, due 
to the inconsistency among the results present, further research on PPT and aerobic exercise is 
needed. In the current study the exercise intensity was individually tailored for each subject 
on the basis of AT, which eliminates genetically predispositions as a source to wrong intensity 
assessment because the age predicted maximum heart rate does not apply equally to all 
subjects. Adaptation of individual tailored exercise intensity is often missing in the previous 
conducted studies. In addition, previous conducted studies have often (e.g., Gowans et al., 
2001; Richards & Scott, 2002) treated the tender points as a dichotomous variable 
(present/not present), while an average change in PPT for each tender point site might be 
more sensitive in detecting changes in pain perception following an aerobic exercise program. 
The main purposes of this study was to investigate whether FM patients can attain the 
same amount of progress in aerobic fitness as healthy matched sedentary controls, following a 
12 week aerobic exercise program with low to moderate intensity. A second objective was to 
investigate whether the exercise program enhanced PPT among FM patients.  
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Method and materials  
Subjects and study design 
Fifty female subjects (25 patients and 25 controls), age ranging from 40 to 65 years, 
were recruited to participate in the study. The FM patients were recruited mainly through the 
local FM association, but some were also recruited through an advertisement in the local 
newspaper. All the FM patients had their FM diagnosis, on the basis of the criterions set by 
the ACR (Wolfe et al., 1990), confirmed by a general practitioner at St. Olavs hospital prior to 
entering the exercise intervention. The controls were also recruited through newspaper 
advertisement, but also through administrative employees at the local university; Norwegian 
University of Science and Technology (NTNU). Subjects who were pregnant, or had other 
illnesses or diseases (high blood pressure, endocrine or metabolic diseases, circulatory 
diseases, stroke, and cardiovascular diseases) apart from FM were excluded from the study. 
Only subjects with none- or low leisure time activity levels were included in the study. The 
study was approved by the local ethical committee, and all subjects gave their written consent 
prior to entering the study. The study was carried out with a case-control design. Patients and 
controls were matched on age (±2 years). In addition, an attempt was also made to match BMI 
between cases and controls.  
 
Pain measurements 
Measurements of PPTs were conducted at 5 different anatomical landmarks using an 
algometer (Somedic algometer type 2, Sweden). These landmarks included; occiput near the 
base of the skull at suboccipital muscle insertions, supraspinatus origin at the superior medial 
scapula corner, trapezius at the middle of its muscle belly, quadriceps femoris tendon just 
proximal to the patella, and rectus femoris approximately 7-8 cm proximal to the quadriceps 
femoris tendon measure site. The probe of the algometer had an area of 1 cm
2
, and the applied 
pressure slope was 40 kPa/s. Measurements were conducted on each side of the body (right 
and left), making a total of 10 PPT measurements (Fig 1).  
All the measurements of PPT were done perpendicular to the PPT sites, while the 
patient was seated on a chair. Subjects were instructed to push the button when the pressure 
from the algometer was perceived as painful. If the subject did not push the button before 
reaching 900 kPa, the measurement of the PPT site was automatically ended.   
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Figure 1. Pressure pain measuring sites. The dots indicate where the PPT measurements were conducted 
(Occiput, supraspinatus origin, trapezius, quadriceps femoris tendon and rectus femoris).  
 
Test Protocol 
An incremental load test was used to assess the AT of each subject (Fig 2). The test 
was performed on a Monarch (939E) ergometer bicycle. Individual seat adjustments were 
made prior to the test. Furthermore, subjects were instructed to cycle in an upright position 
(e.g., not lean their elbows on the handlebars) with a cadence of 60-90 rounds per min. This 
was done to achieve the most similar cycling condition for all the subjects. The first 6 min of 
the test was a warm-up period with a fixed watt load. Starting watt was determined through a 
qualitative assessment of each subject; on the basis of if they, and if so, how much they used a 
bicycle during a regular week. After the warm up period the load was increased with 10W 
every minute until the criterion of a blood lactate more than 4.0 mmol/l, and therefore also AT 
(Sjödin & Jacobs, 1981), was achieved. The blood for the lactate measurements was gathered 
from the fingers. For each lactate measurement the finger was wiped thoroughly to avoid 
perspiration in the lactate sample. The lactate measuring unit was placed perpendicular to the 
blood drop, and was only touching the blood drop, not the skin, during the collection of the 
blood sample. Blood was gathered only 3 times from each finger to avoid problems with 
coagulation. Rating of perceived exertion (RPE) was measured by the Borg scale (6-20), and 
the lactate measurements were performed using a Lactate Pro analyzer. The Lactate Pro has 
proven to be an accurate tool for measuring blood lactate concentrations (Medbøe et al., 2000; 
Saunders et al., 2005), and the Borg Scale have been found to be an appropriate tool to assess 
sub maximal exertion (Grant et al., 1999). Both the Borg Scale assessment and the lactate 
measurements were performed every minute following the warm-up period.  
After the desired blood lactate concentration was achieved (i.e. >4.0 mmol/l), the 
subject was instructed to sit still on the ergometer for 3 min, so that the decrease in heart rate 
following the test could be monitored. Heart rate data was collected throughout the whole test 
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using a heart rate monitor (Polar rs800x). Ventilation and oxygen consumption values during 
the test were measured using a spirometer unit (MetaMax II). Prior to each testing period a 
gas calibration was performed using a reference gas with known oxygen- and carbon dioxide 
concentrations. In addition, volume calibration of the turbines used for measuring the 
spirometric activity was carried out every morning prior to testing, using a 3 liter calibrated 
air syringe. Before each individual test an ambient air calibration was performed to check that 
the spirometric unit was measuring the correct air concentrations in the laboratory (20.93 
oxygen, and 0.03 carbon dioxide). During the test one person was closely monitoring the 
spirometric values to prevent or control for any abnormalities in the data collected, and to 
ensure that spirometric data was collected as correctly as possible from each subject. 
 
Figure 2 - Illustration of the AT test. An initial 6 min warm-up period was followed by an increase in work load 
(10W) every minute until reaching a lactate concentration above 4.0 mmol/l. The number of intervals is just for 
illustrational purposes, since every subject cycled until they reached their AT (i.e >4.0 mmol/l). The B indicates 
when Borg scale and lactate measurements were performed. The test ended with a 3 min relaxation period on the 
ergometer.  
 
Exercise period 
The exercise period was carried out for 12 weeks, with an intention of two sessions for 
each subject every week. Sessions consisted of spinning sessions performed in groups with an 
instructor. Exercise sessions lasted approximately 45-55 min, and were in principle interval 
based, with some differences in build up due to the use of several instructors. A mix of 
patients and controls attended each session. Intensity of the work-out should be below AT, 
and was individually tailored through the AT data for each subject acquired from the test prior 
to the exercise period. Each subject was given a heart rate monitor (Polar FS2C) to wear 
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during the exercise sessions, so that the they could monitor their own heart rate to make sure 
that they did not exceed their heart rate value corresponding to their AT. Random lactate tests 
were performed among the subjects during some of the exercise sessions, to control or 
confirm that the subjects were exercising below their AT.  
 
Statistics 
The distribution of the data was tested by a Shapiro-Wilk normality test. All over, both 
the spirometric and algometric data material was normally distributed, and was therefore 
analyzed with parametric statistical tests. To compare changes from pre- to post-test within 
groups a two-tailed paired-sampled t-test was used, while a two-tailed independent sample t-
test was used to compare groups, as well as changes between the groups. The RPE sub-group 
data showed a non-parametric distribution, and within group changes were therefore analyzed 
by a Wilcoxon-test. A statistical significance level of P≤0.05 was used for all analysis. The 
statistical analysis was performed using SPSS 17.0 (2009) and Microsoft Excel (2007) for 
Windows.  
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Results  
Attrition rates and baseline characteristics  
Of the 50 subjects enrolled to the intervention, 37 (17 patients, 20 controls) 
participated at both pre- and post-testing. Hence, 13 subjects (8 patients, 5 controls) dropped 
out of the exercise program. The reasons for dropout among the 8 patients whom did not 
complete the exercise program were; 5 patients got other diseases which forced them to quit 
the exercise program, one patient listed personal reason, and two of the patient felt that the 
exercise program was too strenuous, and that it made their symptoms worse. For the 5 
controls that dropped out following reasons were given; one got a disease, and 4 controls 
listed personal reasons as of why they chose to drop out of the exercise program. One patient 
did not conclude the spirometric measurements at post-test, and are therefore only included in 
the PPT analysis. Anthropometric data of the subjects who completed the spirometric pre- and 
post-test measurements are shown in Table 1. BMI score at pre-test were the only variable 
that differed significantly between the control and patient group. Due to technical problems 
with the spirometric equipment, and lactate concentration above 4 mmol/l on the first 
measurement, only 32 subjects (14 patients, 18 controls) will be included in the spirometric 
analyses. The exercise attendance rates varied widely between subjects. Average attendance 
rate was 72 % (range 20-100) for the patient group and 81 % (range 16-100) for the control 
group, respectively. Due to the variation in average attendance rate, subgroup analysis was 
performed on the subjects who attend 60% (60 minutes on average each week) or more of the 
scheduled exercise sessions (14 controls, 9 patients).  
 
Table 1. Anthropometric data of the pre- and post-test participants. 
                                       Controls (n = 20)       FM patients (n = 16)                       P* 
Age (yrs)   52.1± 8.8                                 54.8± 7.3                        0.33 
Height (cm)                167± 5.6           164± 6.6             0.14 
Weight pre (kg)   71.2± 10.3        75.2± 8.9             0.23 
Weight post (kg)   71.3± 10.9                     74.8± 9.1                       0.32 
BMI pre (kg/m2)     25.5± 3.4        28.1± 3.2              0.03 
BMI post (kg/m2)  25.6± 3.6         27.9± 3.4             0.06 
Values are mean±SD 
*Independent samples t-test 
  
Pre- and post-test measurements  
Table 2 present pre- and post exercise values for oxygen uptake, work rate, HR, 
respiratory exchange ratio (RER), and RPE at AT (i.e. blood lactate = 4 mmol/l) for all the 
subjects who had sufficient spirometric and lactate data on pre- and post-test (14 patients, 18 
controls). Oxygen uptake (l/min and ml/min/kg) as well as work rate at threshold differed 
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significantly between groups at both pre- and post-test (P<0.04 for all comparisons). In 
contrast, there was no difference in HR (P>0.020 for both comparisons), RER at threshold 
(P>0.15 for both comparisons) or RPE (P>0.40 for both comparisons) between the groups in 
pre- or post-test. There was no significant difference between pre- and post-test within the FM 
group, when all subjects were included (P>0.06 for all comparisons). Within the control 
group on the other hand, a significant increase in oxygen uptake (l/min and ml/min/kg), work 
rate, and RER was found (P<0.04 for all comparisons), while the HR and RPE remained more 
or less unchanged (P>0.42 for both comparisons).  
 
Table 2. Oxygen uptake, work rate, HR, RER and RPE at AT for controls and patients who had 
sufficient spirometric and lactate data on pre- and post-test 
                                            FM patients (n=14)            Controls (n=18)                    P*  
O2 (l/min)             Pre 
                             Post 
                             P** 
1.5±0.3 
1.5±0.3 
0.13 
1.7±0.3 
1.8±0.3 
0.02 
0.03 
0.02 
  
VO2 (ml/min/kg) Pre 
                             Post 
                             P** 
19.3±3.7 
20.7±3.8 
0.08 
23.7±4.7 
25.5±5.7 
0.01 
  0.005 
0.01 
  
Watt (W)              Pre 
                             Post 
                             P** 
69±22 
79±24 
0.06 
88±21 
98±23 
0.001 
0.01 
0.03 
  
HR (bpm)             Pre 
                             Post 
                             P** 
134±14 
134±13 
0.98 
137±18 
141±16 
0.42 
0.50 
0.20 
  
RER                     Pre 
                             Post 
                             P** 
1.00±0.03 
1.01±0.04 
0.64 
1.01±0.02 
1.03±0.04 
0.04 
0.55 
0.15 
  
RPE                      Pre 
                             Post 
                             P** 
14.7±2.5 
15.0±2.1 
0.78 
14.3±1.5 
14.5±1.3 
0.79 
0.53 
0.40 
  
Values are mean±SD 
*Independent samples t-test 
** Paired samples t-test 
Abbreviations: O2 = oxygen consumption, VO2 = oxygen rate, HR = heart rate, RER = respiratory exchange 
ratio, RPE = rating of perceived exertion.  
  
Sub group analysis – patients versus controls 
Table 3 presents change (post values – pre values) in oxygen uptake, work rate, HR, 
RER and RPE at AT in patients versus controls with exercise rate ≥60 % (9 patients, 14 
controls). There was no difference in change between groups indicating that controls and 
patients had similar gain in aerobic fitness in terms of oxygen uptake (l/min and ml/min/kg) 
and work rate. HR at threshold increased slightly in both groups, while the RER and RPE 
remained more or less the same 
11 
 
Table 3. Changes (post-values – pre-values) in oxygen uptake, work rate, HR, RER , and RPE at 
anaerobic threshold for controls and patients. Only subjects with an attendance rate equal to 60% or 
above were included in the analysis.  
                                  FM patients (n=9)      95% CI             Controls (n=14)        95% CI                   P* 
ΔO2 (l/min) 0.11±0.12  (0.03-0.19) 0.15±0.16         (0.06-0.23) 0.56 
ΔVO2 (ml/min/kg) 1.8±1.7 (0.73-2.94) 2.4±2.5  (1.1-3.8) 0.53 
ΔWatt (W) 16±12 (8.4-24.2) 13±11 (7.4-19.3) 0.56 
ΔHR (bpm) 2.3±10.6 (-4.6-9.3) 3.0±11.3 (-1.9-8.0) 0.87 
ΔRER 
ΔRPE 
0.01±0.05 
0.4±1.8 
(-0.01-0.04) 
(-0.7-1.6) 
0.02±0.03 
-0.2±1.8 
(-0.01-0.03) 
(-1.1-0.8) 
0.43 
0.46 
ΔVO2 (%) 9.7±9 (3.6-15.8) 10.6±11 (4.9-15.7) 0.84 
ΔWatt (%) 26±21 (12.4-39.8) 17±21 (6.4-27.1) 0.33 
 
Values are mean±SD 
*Independent samples t-test 
Abbreviations: Δ= change in, O2 =oxygen consumption, VO2 = oxygen rate, HR = heart rate, bpm = beats per 
minute, RER = respiratory exchange ratio, RPE = rating of perceived exertion, % = percentage. 
 
 
Figure 3 shows the average watt production at AT (A), and the average VO2 
(ml/kg/min) rate at AT (B) at both pre- and post-test for patients and control who attended 
≥60% of the exercise sessions. There was a significant difference between patients and 
controls in watt production at pre-test (P=0.02). This difference was no longer significant 
(P=0.06) at the post-test. For the VO2 rate there was also a significant differences at pre-test 
(P=0.01), but this was also attenuated to non-significant at post-test (P=0.08). 
 
Figure 3 - A: Average watt production at anaerobic threshold at pre- and post test among both FM patients and 
controls. B: Average VO2 (ml/kg/min) at anaerobic threshold at pre- and post test among both FM patients and 
controls. Only subjects with attendance rates above 60% (patients n=9, controls n=14) are included. 
* indicates significant difference between the groups (P<0.05). 
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Sub-group analysis - changes within the patient group 
 Table 4 present change (post values – pre values) in oxygen uptake, work rate, HR, 
and RER at AT in patients with an exercise rate ≥60 % (9 patients) compared to the patients 
with <60% exercise rate (5 patients). A significant difference in change in oxygen rate 
(ml/min/kg) and work rate was found between the groups (P<0.03 for both comparisons). 
Oxygen consumption (l/min) increased in the ≥60 % group and decreased in the <60 % group 
but failed to generate any significant difference in change between the groups (P=0.08). 
Furthermore, HR and RER did not change significantly between the groups (P>0.23 for both 
comparisons).  
 
Table 4. Changes (post-values – pre-values) in oxygen uptake, work rate, HR, and RER at AT for 
patients with more than- and less than 60% attendance rate. 
                                                   FM >60% (n=9)              FM <60% (n=5)                        P* 
ΔO2 (l/min)    0.11±0.12         -0.03±0.13  0.08 
ΔVO2 (ml/min/kg)    1.8±1.7   -0.4±1.7 0.03 
ΔWatt (W)    16±12  -6±9   0.005 
ΔHR (bpm)    2.3±11  -4.4±6.5 0.23 
ΔRER    0.01±0.04  -0.01±0.06 0.42 
ΔVO2 (%)    9.7±9.0  -2.0±8.8 0.05 
ΔWatt (%)    26±20  -8±9   0.005 
 
Values are mean±SD 
*Independent samples t-test 
Abbreviations: Δ= change in, O2 =oxygen consumption, VO2 = oxygen rate, HR = heart rate, bpm = beats per 
minute, RER = respiratory exchange ratio, % = percentage. 
 
 
Rating of perceived exertion (RPE) 
Figure 4 shows the RPE (measured with the Borg scale) at AT at pre-test, against the 
same fixed watt load at post-test. There is a tendency that both controls and patients are 
located below the line of identity, suggesting a lower RPE at post-test compared to pre-test at 
a fixed watt load. However, the change in RPE did not reach significance (P=0.13 for 
patients, P=0.06 for controls). 
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Figure 4 - Perceived exertion measured by the Borg scale at anaerobic threshold at pre-test, with the same fixed 
watt load at post-test. Only the subjects with attendance rates ≥60% (patients n=9, controls n=14) are included. 
Line of identity is indicated by the dotted line.  
 
 
Pressure pain threshold within the patient group 
Table 5 present PPT values at pre- and post exercise testing among patient with 
attendance rate ≥60%. Overall changes were small and did not reach significance for any of 
the recorded tender point sites (P>0.11 for all comparisons). Similar results were also 
obtained when including all patients (n=17) that performed both the pre- and post PPT testing 
in the analysis (P>0.06 for all comparisons). 
 
Table 5. Pressure pain threshold (kPa) at pre-test, and post-test among patients with attendance rate 
above or equal to 60% (n=11). 
                                                        Pre test                  Post test                        Δ                                P* 
Occiput R 226±73 196±93 -30 0.19 
Occiput L 156±58 160±65 4 0.74 
Supraspinatus R 220±67 225±65 5 0.88 
Supraspinatus L 187±76 210±90 23 0.50 
Trapezius R 157±53 194±79 37 0.26 
Trapezius L 152±50 178±54 26 0.11 
Quadriceps tendon L 292±180 292±136 0 1.00 
Quadriceps tendon R 339±214 329±159 -10 0.85 
Rectus femoris R 317±204 330±151 13 0.82 
Rectus femoris L 305±152 324±172 19 0.66 
 
Values are mean±SD 
Paired samples t-test 
Abbreviations: Δ= change, R = right side of the body, L = left side of the body 
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Discussion 
The main finding of this study was that female FM patients had the same ability to 
enhance their aerobic fitness as age matched controls following a 12 week aerobic exercise 
program. However, a prerequisite to achieve these physiological benefits was to attend the 
scheduled exercise sessions on a regular basis (i.e. ≥60%, which equals 1.2 times each week 
or approximately 60 min per week). This was seen through an almost 10% increase in VO2 
and 26% increase in watt production at AT for the patients who exercised regularly, compared 
to a 2% decrease in VO2 and 8% decrease in watt production at AT for the patients who 
attended less than 60% of the exercise sessions (P≤0.05 for both comparisons). Moreover, 
both the FM patients and controls who attended 60% or more of the scheduled exercise 
sessions improved their oxygen rate (ml/min/kg) by an average of roughly 10%, and the watt 
production at AT increased with an average of 26% for the FM patients and 17% for the 
controls, respectively. This increase in aerobic capacity indicates that the prescribed exercise 
intensity was adequate to facilitate a positive enhancement of the aerobic fitness in both 
patients and controls who attended a sufficient number of exercise sessions (≥60%). An 
exercise intensity below AT seems therefore to be sufficient to enhance aerobic fitness in 
sedentary FM patients, which is in accordance with Busch and co-workers (2008) 
recommendations, i.e., exercise prescribed for FM patients should be of  low to moderate 
intensity to best reduce post exercise pain.  
 A significant difference in aerobic fitness characteristics between female FM patients 
and healthy matched sedentary controls were observed both prior to, and after the exercise 
program. This result is in accordance with previous findings by Valim and co-workers (2002), 
who reported inferior oxygen consumption and lower watt production at AT in female FM 
patients compared to healthy age-matched sedentary controls. The reason for the reduced 
aerobic capacity among FM patients is so far unknown, i.e., it can be a consequence of the 
illness, or it can be induced from deconditioning due to lower physical activity levels among 
FM patients. Both monitoring of physical activity (Kop et al., 2005), and self-reported levels 
of physical activity (Natvig et al., 1998; Bjørkgren et al., 2009) have failed to identify any 
evident difference in average physical activity among FM patients compared to healthy 
sedentary controls. However, the monitorial study by Kop and co-workers (2005) did find a 
significant lower amount of high intensity activity among FM patients compared to healthy 
controls. The importance of this reduced high intensity activity among the FM patients might 
be limited due to the findings done by van Santen and co-workers (2002b), who showed that 
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high intensity exercise are not superior in enhancing aerobic fitness in FM patients compared 
to exercise with low to moderate intensity.  
Several studies have attempted to link the apparent reduced aerobic fitness among FM 
patients, compared to healthy controls, to the pathophysiology of the FM syndrome. Sahin 
and co-workers (2004) found evidence suggesting a lower maximal ventilation volume in FM 
patients compared to matched healthy controls, while Dinler and co-workers (2009) suggested 
that female FM patients may have a dysfunctional cardiopulmonary system compared to 
sedentary controls, due to longer recovery half times for oxygen turnover. Lindh and co-
workers (1995) showed a lower capillary network in muscles of FM patients compared to 
healthy controls. A lower capillary density would give less oxygen delivery to working 
muscles, and in that way result in an earlier transition from aerobic to anaerobic energy 
utilization, thus inducing a premature AT in FM patients compared to healthy controls. 
However, lower maximal ventilation volume, longer recovery half times for oxygen turnover, 
and reduced capillary density might as well be a result from more sedentary behavior among 
FM patients compared to healthy subjects, and in that way not have a direct connection to the 
FM pathophysiology. The FM patients, who participated in a sufficient number of exercise 
sessions (≥60%) in this study, were equally exercisable as their matched healthy controls. 
This finding indicates that the reduced aerobic fitness found among the FM patients is mainly 
due to deconditioning from sedentary behavior, rather than a dysfunctional metabolic system.  
Regular participation in physical activity to improve aerobic fitness has been found to 
protect against development of cardiovascular diseases (Blair et al., 1996; Macera et al., 
2003), and some types of cancer (Lee, 2003). Recently a prospective cohort study showed that 
widespread musculoskeletal pain is associated with increased mortality from cancer, and 
possibly cardiovascular diseases (McBeth et al., 2009). Since the major symptom of FM is 
widespread musculoskeletal pain, these findings are likely to apply to FM patients. In other 
words; FM patients are probably more at risk for cancer and cardiovascular related deaths 
than subjects without chronic widespread pain. Our study found on average a considerable 
lower aerobic fitness level among the FM patients compared to matched controls, similar 
results have also have been reported earlier (Valim et al., 2002). These findings emphasize 
that regular physical activity to improve aerobic fitness might be even more important for FM 
patients than healthy sedentary controls. Not only because of the observed lower aerobic 
fitness among FM patients in this study, but also due to their widespread musculoskeletal 
pain. A combination of these risk factors could generate a substantial higher risk of cancer 
16 
 
and cardiovascular related mortality among FM patients, compared to healthy subjects. Our 
exercise program generated on average a significant improvement in aerobic fitness among 
the FM patients who attended 60% or more of the scheduled exercise sessions. In other words, 
a minimum of approximately 60 min of exercise per week were on average enough to 
improve aerobic fitness among the FM patients. This is a relatively small amount of weekly 
exercise, and should therefore be endurable for most FM patients. In addition, only small 
changes in physical activity among sedentary females have been associated with a large 
reduction in mortality from cardiovascular diseases (Oguma & Shinoda-Tagawa, 2004). To 
sum up, it is important to motivate FM patients to carry out regular exercise, since only small 
amounts of weekly exercise seem to improve aerobic fitness which in turn would reduce 
mortality associated with cardiovascular diseases, and some types of cancer.  
RPE level measured by the Borg scale had a tendency, though not significant (P=0.13 
for patients, P=0.06 for controls), to be lower on a fixed watt load on the post-test compared 
to the pre-test for both controls and patients who attended 60% or more of the scheduled 
exercise sessions. This indicates that most subjects felt that a fixed watt load was easier to 
maintain after the exercise period compared to before the exercise intervention. Reduced RPE 
at a fixed watt load on post-test compared to pre-test is presumably a consequence of the 
increase in aerobic fitness experienced by patients and controls who attend 60% or more of 
the scheduled exercise sessions. This may also have positive effects on daily activities, i.e. 
lesser the feeling of fatigue which is one of the most prominent symptoms in FM patients. 
In contrast to Nielens and co-workers (2000) and Cook and co-workers (2006), who 
found a difference in RPE between controls and FM patients, this study did not observed any 
difference between FM patients and healthy controls in Borg scores at AT either at pre- or 
post-test (P>0.40 for both comparisons). The reason for the inconsistent findings between this 
study and the previous conducted studies might be the difference at which intensity the RPE 
was measured. Nielens and co-workers calculated the Borg on 65% of maximum heart rate, 
while Cook and co-workers used ventilatory threshold instead of AT as basis for the 
assessment. Furthermore, the patients in the study by Cook and co-workers suffered from 
chronic fatigue syndrome in addition to FM. Thus it seems likely that the Borg scale is 
equally applicable to FM patients as healthy matched controls as a tool for assessing RPE at 
AT. However further research on a larger sample size are needed to confirm these results.  
Pressure pain threshold (PPT) did not improve significantly among the FM patients 
from pre- to post test. This is in accordance with earlier findings (Gowans et al., 2001). The 
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average improvement in PPT, though not significant (P>0.06 for all comparisons), were 
larger when all the patients were included compared to when only the patients with attendance 
rates above or equal to 60% were analyzed. This suggests that there were no correlation 
between exercise volume and change in PPT status. Sabbag and co-workers (2007) found an 
increase in aerobic fitness among FM patients after the first 3 months of their 1 year exercise 
intervention, but did not observe any changes in PPT. However, a significant improvement in 
average PPT was found after 9 months. These findings indicate that a 12 week or 3 month 
exercise intervention might be adequate to improve aerobic fitness, but on the other hand too 
short to facilitate any significant positive enhancement of PPTs in FM patients. A recent study 
by McVeigh and co-workers (2007) investigated the fluctuation of PPT at the 18 tender point 
sites defined by the American College of Rheumatology. Their results indicate a stability of 
PPT throughout a period of 28 days. Thus a fluctuation would not likely be the reason for the 
lack of change in PPT throughout the exercise program. However, PPT is also a subjective 
evaluation of pain, and day to day variation in mood or presence of comorbidities might 
influence the result. Changes in PPT following aerobic exercise interventions seems 
inconsistent, the reason for this inconsistency might be due to the variation in severity of the 
illness in each FM patient, which in turn reflects the heterogeneity among the FM patients. 
This makes it important to individually tailor exercise programs for each FM patients, to best 
reduce pain (Mannerkorpi & Iversen, 2003). A greater understanding of the pathophysiology 
behind FM, combined with a larger sample, in a long term aerobic exercise program might 
produce better understanding of how PPT can be altered. 
There are several limitations to this study. Our study only included subjects that 
participated in none or low levels of leisure time exercise activities. Since the selection was 
done on the basis of self-reported physical exercise, it might be that some of the subjects did 
not consider activities they practiced as physical exercise. For instance; walking the dog for 
an hour each day might not be perceived as physical exercise by some of the subjects, 
however compared to a person who is completely sedentary this will probably count as 
physical exercise. Therefore some self-reporting bias may have occurred, furthermore causing 
a disparity in aerobic fitness between the FM patients and the controls.  
High attrition rates in exercise intervention among FM patients are not uncommon 
(Mengshoel et al., 1992; Rooks et al., 2002). This study was not an exception, with as many 
as one third (33 %, n=8) of the patients dropping out from the exercise program. In addition, 5 
patients did not attend sufficient exercise sessions (i.e. ≥60%) to generate the increase in 
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aerobic fitness associated with this exercise program. Leaving only 46% (n=11) of the 
patients completing a sufficient number of exercise sessions throughout the 12 weeks. 
Mannerkorpi and Iversen (2003) emphasized the need for an individual tailored exercise 
program for FM patients, due to the heterogeneity of this patient group. This study succeeded 
in individualizing the exercise intensity for each patient, which in turn excluded the 
possibility of too high exercise intensity, and in that way reduced the likelihood of attrition on 
the basis of too strenuous intensity (van Santen et al., 2002b). Still 2 patients dropped out 
because they felt a worsening of their symptoms. Another issue is the choice of spinning as 
exercise method. Since this study only consisted of spinning sessions, it might be that this 
type of exercise did not appeal to all of the patients due to the presence of comorbidities, this 
may in turn be a reason for the reduced adherence among the patients to the exercise program. 
Furthermore, this study did not include any educational component towards the management 
of FM, and inclusion of such a component may have increased the adherence to the exercise 
program among the patients (Hauser et al., 2009). On the other hand, it is well documented 
that FM patients suffer from a range of additional symptoms other than pain (Clauw, 1995; 
Epstein et al., 1999), and since 5 patients gave other diseases as reason for their drop outs, it 
seems likely that interference from other disease might be an important reason for the high 
attrition rates experienced in this intervention.  
In conclusion, this study indicate that female FM patients can improve their aerobic 
fitness to the same extent as healthy sedentary controls following a 12 week aerobic exercise 
program with low to moderate intensity. This is important since low to moderate exercise 
intensity are associated with less post-exercise pain in FM patients compared to high intensity 
exercise. Furthermore, a substantial lower aerobic fitness was observed among the FM 
patients compared to the healthy controls. The reduced aerobic fitness is more likely to be a 
result from more sedentary behavior rather than a dysfunctional metabolic system, due to the 
similar progress in aerobic fitness between FM patients and healthy controls. However, 
further research is needed on the level of physical activity among FM patients compared to 
healthy controls, especially monitorial studies. Furthermore, a better understanding of the FM 
pathophysiology could also contribute to a wider understanding of the reduced aerobic fitness 
in FM patients.  
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